Patents by Inventor Thomas Berglindh

Thomas Berglindh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nucleic acid and amino acid sequences relating to Helicobacter pylori for diagnostics and therapeutics
    Publication number: 20040052799
    Abstract: Recombinant or substantially pure preparations of H. pylori polypeptides are described. The nucleic acids encoding the polypeptides also are described. The H. pylori polypeptides are useful for diagnostics and vaccine compositions.
    Type: Application
    Filed: December 30, 2002
    Publication date: March 18, 2004
    Applicant: Astra Aktiebolag
    Inventors: Douglas Smith, Richard A. Alm, O. Thomas Berglindh, Bjorn L. Mellgard, Steven R. Thomas, Eric Brown, Donald T. Moir, Lo See Ling, Gilles Carmel, Braydon C. Guild, Peter C. Doig, Zita Kabok, Lillian Marie Castriotta
  • VACCINE COMPOSITION COMPRISING HELICOBACTER PYLORI FLAGELLIN POLYPEPTIDE
    Publication number: 20020028210
    Abstract: The present invention relates to a vaccine composition for inducing a protective immune response to Helicobacter pylori infection, said composition comprising an immunogenically effective amount of a polypeptide comprising at least one Helicobacter pylori flagellin polypeptide, optionally together with a pharmaceutically acceptable carrier or diluent.
    Type: Application
    Filed: December 3, 1997
    Publication date: March 7, 2002
    Inventors: THOMAS BERGLINDH, INGRID BOLIN, BJORN MELLGARD, ANN-MARI SVENNERHOLM
  • N-heterocyclic substituted salicylic acids
    Patent number: 5556855
    Abstract: A compound of the formula Het--NR--SO.sub.2 --Ph.sup.2 --A--Ph.sup.1 (COOH)(OH) and tautomic form, salts, solvates, C.sub.1-6 alkyl esters and pharmaceutical compositions of the compound. Ph.sup.1 and Ph.sup.2 are benzene rings with the proviso that carboxy and hydroxy are ortho to one another. Het includes an optionally substituted heterocyclic ring which includes conjugated double bonds and binds to nitrogen in NR. The compound is characterized in that A is a bridge which is stable against reduction because it is not azo, and in that R is hydrogen or lower alkyl.The invention also includes the preparation of the compound and its use as a drug, particularly for treating autoimmune diseases.
    Type: Grant
    Filed: December 29, 1994
    Date of Patent: September 17, 1996
    Assignee: Pharmacia AB
    Inventors: Hubert Agback, Leif Ahrgren, Thomas Berglindh, Martin Haraldsson, G oran Smedeg.ang.rd, Lars-Inge Olsson
  • Substituted salicylic acids
    Patent number: 5403930
    Abstract: A compound of the formula Het--NR--SO.sub.2 --Ph.sup.2 --A--Ph.sup.1 (COOH)(OH) and tautomic form, salts, solvates, C.sub.1-6 alkyl esters and pharmaceutical compositions of the compound. Ph.sup.1 and Ph.sup.2 are benzene rings with the proviso that carboxy and hydroxy are ortho to one another. Het includes an optionally substituted heterocyclic ring which includes conjugated double bonds and binds to nitrogen in NR. The compound is characterized in that A is a bridge which is stable against reduction because it is not azo, and in that R is hydrogen or lower alkyl.The invention also includes the preparation of the compound and its use as a drug, particularly for treating autoimmune diseases.
    Type: Grant
    Filed: October 7, 1993
    Date of Patent: April 4, 1995
    Assignee: Pharmacia AB
    Inventors: Hubert Agback, Leif Ahrgren, Thomas Berglindh, Martin Haraldsson, Goran Smedeg.ang.rd, Lars-Inge Olsson
  • Therapeutical composition comprising hydrolyzed carboxylalkyl cellulose
    Patent number: 5324717
    Abstract: A therapeutical composition comprising hydrolyzed carboxyalkyl cellulose, wherein alkyl is methyl, ethyl or propyl, optionally in salt form, which hydrolyzed carboxyalkyl cellulose has a mass average molecular mass from about 200 to about 10,000. A method for providing a laxative effect comprises the administration of such a composition.
    Type: Grant
    Filed: November 4, 1992
    Date of Patent: June 28, 1994
    Inventors: Thomas Berglindh, Anthony de Belder
  • Compounds containing an amino salicylic acid moiety linked to a sulphapyridine moiety via stable bridge
    Patent number: 5302718
    Abstract: A compound of the formula Het--NR--SO.sub.2 --Ph.sup.2 --A--Ph.sup.1 (COOH)(OH) and tautomeric form, salts, solvates, C.sub.1-6 alkyl esters and pharmaceutical compositions of the compound. Ph.sup.1 and Ph.sup.2 are benzene rings with the proviso that carboxy and hydroxy are ortho to one another. Het includes an optionally substituted heterocyclic ring which includes conjugated double bonds and binds to nitrogen in NR. The compound is characterized in that A is a bridge which is stable against reduction because it is not azo, and in that R is hydrogen or lower alkyl.The invention also includes the preparation of the compound and its use as a drug, particularly for treating autoimmune diseases.
    Type: Grant
    Filed: November 9, 1992
    Date of Patent: April 12, 1994
    Assignee: Kabi Pharmacia AB
    Inventors: Hubert Agback, Leif Ahrgren, Thomas Berglindh, Martin Haraldsson, Goran Smedegard, Lars-Inge Olsson